Australia markets closed

ImmuCell Corporation (ICCC)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
9.28+0.07 (+0.76%)
At close: 4:00PM EDT
Full screen
Trade prices are not sourced from all markets
Previous close9.21
Open9.22
Bid8.80 x 1000
Ask9.99 x 900
Day's range8.85 - 9.28
52-week range5.21 - 13.20
Volume870
Avg. volume10,675
Market cap71.844M
Beta (5Y monthly)0.87
PE ratio (TTM)N/A
EPS (TTM)-0.06
Earnings date15 Nov 2021
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target estN/A
  • GlobeNewswire

    ImmuCell Announces Record Preliminary, Unaudited Sales Results for Third Quarter of 2021

    PORTLAND, Maine, Oct. 06, 2021 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”), a growing animal health company that develops, manufactures and markets scientifically-proven and practical products that improve the health and productivity of dairy and beef cattle, today announced preliminary, unaudited sales results for the third quarter ended September 30, 2021. Preliminary, Unaudited Total Sales Results: 2021 2020 $ Increase % IncreaseDuring the Three-Month

  • GlobeNewswire

    Raffael Lichdi, DVM Joins ImmuCell’s Sales & Marketing Team

    PORTLAND, Maine, Sept. 14, 2021 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”), a growing animal health company that develops, manufactures and markets scientifically-proven and practical products that improve the health and productivity of dairy and beef cattle, today announced the expansion of its commercial team with the hiring of Dr. Raffael Lichdi as Commercial Research & Technical Services Veterinarian. Dr. Lichdi blends exceptional technical know-how

  • Simply Wall St.

    Is ImmuCell (NASDAQ:ICCC) Weighed On By Its Debt Load?

    The external fund manager backed by Berkshire Hathaway's Charlie Munger, Li Lu, makes no bones about it when he says...